Covenant Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.71M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$1.63M |
| 3 |
Atlassian
TEAM
|
+$1.34M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
+$1.17M |
| 5 |
Steris
STE
|
+$1.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$662K |
| 2 |
DexCom
DXCM
|
+$551K |
| 3 |
Estee Lauder
EL
|
+$509K |
| 4 |
Aptiv
APTV
|
+$399K |
| 5 |
Medtronic
MDT
|
+$392K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.33% |
| 2 | Healthcare | 7.46% |
| 3 | Financials | 6.05% |
| 4 | Industrials | 5.3% |
| 5 | Consumer Discretionary | 3.58% |
Similar funds
Covenant Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Covenant Partners held 200 positions worth $275M, down 0.51% from $277M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Covenant Partners deployed $10.7M of net new capital in Q3 2023, opening 20 new positions and adding to 26 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 20,591 shares worth $1.53M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $329K trimmed.
- Covenant Partners's largest Q3 2023 buy was Canadian Pacific Kansas City: 20,591 shares worth $1.53M.
- Covenant Partners added most to iShares MSCI EAFE Value ETF in Q3 2023, an estimated $1.71M increase.
- Covenant Partners's biggest Q3 2023 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $329K.
- Covenant Partners fully exited Nike in Q3 2023, selling an estimated $662K.
- Covenant Partners's ten largest holdings make up 61% of its $275M portfolio in Q3 2023.
- Covenant Partners opened 20 new positions and closed 19 in Q3 2023.
- Covenant Partners's portfolio value fell 0.51% quarter-over-quarter to $275M.
Based on Covenant Partners's 13F filing for Q3 2023, filed 20 Oct 2023.